Search results
Showing 691 to 705 of 2105 results for technology appraisal
Evidence-based recommendations on pembrolizumab (Keytruda) for relapsed or refractory classical Hodgkin lymphoma in people 3 years and over.
Leriglitazone for treating cerebral adrenoleukodystrophy in people 2 years and over [ID3903]
In development Reference number: GID-HST10069 Expected publication date: TBC
NICE public committee meetings supports our commitment to having processes in place that are rigorous, open, and transparent.
NICE public committee meetings supports our commitment to having processes in place that are rigorous, open, and transparent.
Evidence-based recommendations on dapagliflozin (Forxiga) for treating chronic heart failure with preserved or mildly reduced ejection fraction in adults.
Gemtuzumab ozogamicin for untreated acute myeloid leukaemia (TA545)
Evidence-based recommendations on gemtuzumab oxogamicin (Mylotarg) for untreated acute myeloid leukaemia in people aged 15 years and over.
Awaiting development Reference number: GID-TA11085 Expected publication date: TBC
In development Reference number: GID-TA11694 Expected publication date: 10 February 2027
Awaiting development Reference number: GID-TA11342 Expected publication date: TBC
Evidence-based recommendations on nivolumab (Opdivo) with fluoropyrimidine- and platinum-based chemotherapy for untreated unresectable advanced, recurrent, or metastatic oesophageal squamous cell carcinoma in adults.
Awaiting development Reference number: GID-TA11695 Expected publication date: TBC
Awaiting development Reference number: GID-TA11716 Expected publication date: TBC
Navepegritide for treating achondroplasia in people 2 to 15 years [ID6538]
Awaiting development Reference number: GID-TA11699 Expected publication date: TBC
Obinutuzumab for untreated advanced follicular lymphoma (TA513)
Evidence-based recommendations on obinutuzumab (Gazyvaro) for untreated advanced follicular lymphoma in adults.
Evidence-based recommendations on mepolizumab (Nucala) for treating severe eosinophilic asthma in adults.